5 studies found
Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity
OncoTrack attempts to address the core problems of drug-based cancer therapies: the low response rate of patients to their therapies, as well as its inevitable consequence, the low approval rates of oncology drugs. Only about 10% of cancer drug candidates entering clinical development are granted marketing authorization. Our program is based on two seminal developments: significant progress in our ability to analyze the molecular characteristics of individual tumors and patients (predominantl...
Preclinical toxicological assessment in animal models